About us

Leukaemia Care is the UK’s leading leukaemia charity. For over 50 years, we have been dedicated to ensuring that everyone affected receives the best possible diagnosis, information, advice, treatment and support.

Contact us

For all general enquiries, information about events, fundraising or anything else, including requests for resources get in touch with us today using any of the details below.

Who we are and what we do

Leukaemia Care is the UK’s leading leukaemia charity.

Our strategic plan

We exist to improve the lives of everyone affected by leukaemia, MDS and MPN. Over the last 50 years, we have come a long way, but there is more to be done.

Our Trustee Board

Here at Leukaemia Care we have a small but dedicated trustee board. Find out more about each member here…

Meet our Patrons and Ambassadors

Our Patrons help to raise awareness of our charity, blood cancers and issues facing patients and their families. We are grateful to them all for their wonderful support.

Vacancies

Find out more about the latest vacancies at Leukaemia Care.

Volunteering opportunities

Contribute your time and expertise to enhance the lives of those impacted by leukaemia through volunteering with us.

Privacy policy

The Leukaemia Care privacy policy as of 6th March 2024

Press and media centre

Looking to write an article about Leukaemia? We've got some of the facts and statistics that you can quote.

Annual accounts and reports

View our annual reports and financial statements.

Fundraising promise

Supporters drive everything we do at Leukaemia Care. It’s thanks to your generosity that we are able to support so many leukaemia patients, read on to learn more about our fundraising promise.

Our complaints procedure

Read more about our complaints procedure below.

Treatments for CLL

Chronic lymphocytic leukaemia (CLL) is generally very treatable. The main treatments are usually targeted medicines designed to attack CLL cells. Some people have antibody therapy alongside a targeted medicine. Find out about your treatment options and how supportive care can help you too.

Read More

Take a Moment to Catch Up

View our latest news and blog articles

February 21st

Leukaemia Care Welcomes NICE Approval of Blinatumomab for Final Group of ALL Patients

Leukaemia Care welcomes NICE's approval of blinatumomab for wider availability to all those living with ALL, bringing hope for relapse prevention and an improved quality of life....

December 12th

Leukaemia Care Winter Appeal: Wrapped wishes of gratitude, highlighting the impact of our support

This Winter, we’re wrapping gift tags around Leukaemia Care HQ, filled with heartfelt messages of support and gratitude from those who have benefited from our vital support services....

November 11th

Additional treatment for AML patients now available in Scotland

Leukaemia Care is pleased to announce that newly diagnosed acute myeloid leukaemia (AML) patients with a FLT3 mutation now have access to quizartinib, in combination with chemotherapy, thanks to a decision made by the Scottish Medicines Consortium (SMC) today. ...